PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Colca, Jerry
TI  - Mitoglitazone and PPAR-Sparing Insulin Sensitizers
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 17--19
VI  - 8
IP  - 7
4099  - http://mdc.sagepub.com/content/8/7/17.short
4100  - http://mdc.sagepub.com/content/8/7/17.full
AB  - Activation of peroxisome proliferator-activated receptor (PPAR) is associated with dose-limiting side effects, such as edema and bone loss. This article describes recent efforts in the development of PPAR-sparing insulin sensitizers.